CHRS vs XLU
Coherus BioSciences Inc (CHRS) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
XLU (XLU) common stock.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
XLU does not have a complete income-statement cache yet.
CHRS currently screens at market cap $223.7M. XLU currently screens at market cap $0.
Not investment advice. Open the CHRS and XLU stock pages for the full models.
Not investment advice.